Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only! Grab it Watch a detailed analysis of a 2021 case series examining Fenbendazole (FBZ), a veterinary anti-parasitic medication, and its potential anti-tumor effects in human cancer treatment. Explore three documented cases where patients with various genitourinary malignancies showed complete response after FBZ therapy, either as a standalone or supplementary treatment. Learn about the medication's mechanism of action, similar to anti-oncogenic vinca alkaloids, and its application in cases where traditional treatments had failed. Discover how patients taking 1 gram three times weekly showed tumor reduction without reported side effects. Examine the detailed medical histories, treatment protocols, and imaging results that demonstrate FBZ's potential as a safe and effective antineoplastic agent, while understanding the current limitations in clinical literature and the need for further research to define its role in cancer treatment.